Topics:

State-of-the-art Clinical Facilities

Inquiries

Volunteer lenexa

We provide end-to-end bioanalytical support from Pre-Clinical to Phase IV studies.

At PRA, our laboratories are managed, staffed, and supported by industry-leading experts who have the scientific knowledge and experience to successfully deliver even the most complex of studies.

Our clinics

We operate state-of-the-art facilities in the Netherlands and North America, as well as an innovative patient pharmacology model in Central and Eastern Europe. In addition, our laboratory facilities are situated close to our clinical facilities and configured to support all study requirements.

Lenexa, Kansas, USA

From First-in-Human to Proof-of-Concept programs, we can help take your product from concept to compound to cure.

Our strategically located, state-of-the-art clinical research center in Lenexa, Kansas has 114 patient beds and a GCP-practicing pharmacy. We can handle all types of formulations in our temperature- and humidity-controlled setting and our co-located bioanalytical laboratory ensures rapid sample processing for critical, dose-escalation, and decision-making involving pharmacokinetic assays.

We have extensive experience in:

  • Focused First-in-Human studies through Proof-of-Concept
  • Vaccine studies

Salt Lake City, Utah, USA

We’re shaping the future of clinical research at our state-of-the-art Phase I Clinic in Salt Lake City, Utah.

Our 136-bed Salt Lake City clinic was custom-built for First-in-Human and early phase studies in healthy volunteers and patients. We are strategically located across the street from a trauma hospital and can fully support timely, efficient data collection while always ensuring the safety of each study participant. We also provide dedicated patient wards, private dosing rooms, and flexible space to accommodate your rigorous assessment needs.

Our meticulously designed investigative unit supports the precise execution of all early phase clinical trials. Although we’re capable of conducting studies across all therapeutic areas, we have a particular focus in CNS with neurology and psychiatry specialization, analgesia, abuse liability, and sleep medicine.

Groningen, the Netherlands

From First-in-Human to Proof-of-Concept programs, we can help take your product from concept to compound to cure.

Our 150-bed Clinical Pharmacology Unit in Groningen, the Netherlands is strategically located and directly connected to the Martini Hospital, including direct access to their intensive care unit. This partnership ensures we have access to the latest tools, technology, and expertise, including:

We have extensive experience in:

  • Positron emission tomography (PET)
  • Functional magnetic resonance imaging (fMRI) scans
  • Cerebral spinal fluid (CSF) sampling
  • Validated pain models
  • Cognitive testing
  • Spirometry
  • Radio-isotope studies with 14C and 3H, including ADME studies

Budapest, Hungary

Providing accessible Phase I solutions throughout Hungary.

Our Budapest clinic focuses on oncological, ADME, and mass balance studies, as well as rheumatology and renal impairment studies. As one of only 14 accredited Phase I units in Hungary, our centrally-located clinic is easily accessible to patients and is within close proximity of additional hospital services if required. We’ve also developed excellent working relationships with university clinics and top institutions throughout the region to ensure we provide the safest, most effective solutions.

Prague, Czech Republic

Conducting safe, effective Phase I and II studies.

Based in Prague, Czech Republic, we conduct clinical trials on pharmaceuticals, pharmacokinetics, and pharmacodynamics of investigational products. We primarily focus on Phase I and II studies that utilize special patient populations with renal and hepatic diseases, diabetes, and rheumatoid arthritis.

Curious to learn more about our capabilities?

Read more

You may also be interested in:

Corporate Responsibility page

Corporate Responsibility

We’re in the business of improving lives, but drug development isn’t the only way we’re doing it. While bringing new treatments to market is…

Read More
Alzheimer's Disease Research 2018 White Paper

Alzheimer's Disease Research 2018

PRA conducted a survey at the 2018 Alzheimer's Association International Conference in Chicago. Across the board we found that the research community…

View Resource
Challenges Arise as the Need for Pediatric Research Increases Blog

Challenges Arise as the Need for Pediatric Research Increases

Many modern providers prescribe off-label treatment to children with “guesstimated” doses, because these drugs have often only been studied in…

Read Story

View all related content and resources for Patient Recruitment and Retention

Explore Insights